Philippe Gabriel Steg

Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France
Faculty of Medicine, Université de Paris, Paris, France
INSERM U-1148, Laboratory for Vascular Translational Science, Paris, France

Dr. Steg has accumulated experience as a clinical trialist in the field of coronary artery disease, diabetes and antithrombotics. He is currently chair/co-chair or principal investigator of several large phase III clinical trials or international registries, such as ODYSSEY-Outcomes, CLARIFY, THEMIS, REALITY, SCORED. He was co-chair of the REACH registry, co-chair of the GRACE registry publication committee and participated in numerous DMCs or CECs. Dr. Steg has authored > 1 000 articles in peer-reviewed international journals. His H-Index is 116 (Web of Science) and he has > 76 000 citations. He has been a Thomson Reuters/Clarivate Analytics “highly cited researcher” in Clinical Medicine every year since 2014. He is Senior Associate Editor for Circulation, and Senior Consultant editor for Eurointervention. He is currently Faculty Head, Cardiovascular Disorders, Faculty of 1000-Prime. Dr. Steg co-chaired with Dr. James the ESC task force in charge of the 2012 Guidelines for management of ST-segment elevation myocardial infarction. Dr. Steg received the silver medal of the European Society of Cardiology in 2011, the Joseph A Vita Award from the American Heart Association in 2019 and the Grand Prix Claude Bernard de la Ville de Paris in 2019.

Areas of Interest

  • Acute coronary syndromes
  • Atherothrombosis
  • Atrial fibrillation
  • Cardiovascular pharmacotherapy
  • Coronary artery disease